E7777
Showing 1 - 25 of 43
Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)
Not yet recruiting
- Epithelial Ovarian Cancer
- Pembrolizumab
- E7777
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Aug 4, 2022
DLBCL, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma Trial in Minneapolis (E7777)
Recruiting
- DLBCL
- +3 more
- E7777
-
Minneapolis, MinnesotaUniversity of Minnesota, Masonic Cancer Center
Jul 1, 2022
Persistent or Recurrent Cutaneous T-Cell Lymphoma Trial in Australia, Puerto Rico, United States (E7777 9 mcg/kg)
Completed
- Persistent or Recurrent Cutaneous T-Cell Lymphoma
- E7777 9 mcg/kg
-
Birmingham, Alabama
- +21 more
Dec 5, 2022
Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma Trial in Japan (E7777)
Completed
- Peripheral T-cell Lymphoma
- Cutaneous T-cell Lymphoma
- E7777
-
Nagoya, Aichi, Japan
- +19 more
Jun 24, 2021
Remitoro in Recurrent or Refractory Peripheral T Cell Lymphoma
Recruiting
- Lymphoma, T-cell, Peripheral
- Lymphoma, T-cell, Cutaneous
-
Nagoya, Japan
- +2 more
Nov 24, 2022
Peripheral T-Cell Lymphoma Trial in Japan (denileukin diftitox (E7777))
Completed
- Peripheral T-Cell Lymphoma
- denileukin diftitox (E7777)
-
Nagoya, Aichi, Japan
- +3 more
Apr 22, 2018
Osteomyelitis, Prosthetic Joint Infection, Diabetic Foot Trial in Germany, Portugal, United Kingdom (Shorter Systemic
Recruiting
- Osteomyelitis
- +2 more
- Shorter Systemic Antibiotics
- Standard treatment
-
Regensburg, Germany
- +22 more
Jan 30, 2023
Trauma, Brain, Mass Lesion, Skull Fractures Trial in United Kingdom (qER (qER EU 2.0))
Recruiting
- Trauma, Brain
- +6 more
- qER (qER EU 2.0)
-
Glasgow, United Kingdom
- +3 more
Aug 30, 2023
Baseline-characteristics of Patients Referred toSecondary Spine
Recruiting
- Spine Disease
- +3 more
- Consultation at spine-centre
-
Heerlen, Limburg, NetherlandsZuyderland MC
Jul 14, 2022
Marijuana Abuse Trial in New York (3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition,
Recruiting
- Marijuana Abuse
- 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition
- 3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fasting condition
-
New York, New YorkSubstance Use Research Center
Jan 25, 2023
Obesity, Morbid, Bariatric Surgery Candidate Trial in Remscheid (upper endoscopy)
Recruiting
- Obesity, Morbid
- Bariatric Surgery Candidate
- upper endoscopy
-
Remscheid, GermanySana obesity center
Mar 21, 2021
Tumors Trial in San Jose del Cabo, Torreon (Anti-Bacterial Agents, Anti-Fungal Agents, Anti-Protozoal Agents)
Recruiting
- Neoplasms
- Anti-Bacterial Agents
- +2 more
-
San Jose del Cabo, Baja California Sur, Mexico
- +1 more
Mar 26, 2022
Heart Failure Trial in Austin (Sensor-controlled digital game (SCDG), Sensor Only)
Not yet recruiting
- Heart Failure
- Sensor-controlled digital game (SCDG)
- Sensor Only
-
Austin, TexasThe University of Texas Austin
Nov 2, 2021
Gastric Cancer Trial in Netherlands (drug, procedure, radiation)
Recruiting
- Gastric Cancer
- Docetaxel
- +6 more
-
Leeuwarden, Friesland, Netherlands
- +27 more
Jan 20, 2022
Education of Health Care Workers on Maintenance of Venous Access
Recruiting
- Vascular Access Devices
- Training and education
-
Chandigarh, IndiaPGIMER
Jan 1, 2021
COPD Trial in New York (Capnometry-Assisted Training for COPD to Slow the Breath (CATCH), Pulmonary Rehabilitation (PR))
Completed
- Chronic Obstructive Pulmonary Disease
- Capnometry-Assisted Training for COPD to Slow the Breath (CATCH)
- Pulmonary Rehabilitation (PR)
-
New York, New YorkNew York University School of Medicine
Jul 26, 2021
INTENT-Muscle (A Sub-study of INTENT)
Recruiting
- Critically Ill
- Supplemental parenteral nutrition
-
Blacktown, New South Wales, Australia
- +5 more
Aug 10, 2021
Heart Failure Trial in Austin (Sensor-controlled digital game (SCDG), Sensor Only)
Completed
- Heart Failure
- Sensor-controlled digital game (SCDG)
- Sensor Only
-
Austin, Texas
- +1 more
Jun 4, 2021
Systemic Lupus Erythematosus Trial (Serum galectin-9 level)
Unknown status
- Systemic Lupus Erythematosus
- Serum galectin-9 level
- (no location specified)
Sep 23, 2020
Parkinson Disease Trial in Durham (IPG; RC+S)
Completed
- Parkinson Disease
- IPG; RC+S
-
Durham, North CarolinaDuke University Medical Center
Mar 6, 2020
Hemophilia A Trial in Worldwide (BIIB031 (rFVIIIFc), FVIII (PK subgroup only))
Completed
- Hemophilia A
- BIIB031 (rFVIIIFc)
- FVIII (PK subgroup only)
-
Los Angeles, California
- +22 more
Dec 16, 2020
Thorough QT/QTc Study Trial in Evansville (Inhaled loxapine, Inhaled , Oral moxifloxacin)
Completed
- Thorough QT/QTc Study
- Inhaled loxapine
- +3 more
-
Evansville, IndianaCovance Clinical Research Unit Inc.
Oct 29, 2019